Skip to main content

Editas Medicine, Inc 10-Q for FY2021 Q3

Editas Medicine, Inc. (EDIT)

10-Q 2021-11-09 For: 2021-09-30
View Original
Added on April 10, 2026

About this 10-Q

Editas Medicine, Inc filed this 10-Q on November 9, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).

Headline figures

Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$6.2M
down 90.1% from $62.84M a year earlier
Net loss
$39.08M
compared with net income of $7.82M a year earlier
Diluted EPS
-$0.57
compared with $0.12 a year earlier